Subantimicrobial-dose doxycycline in the treatment of moderate facial acne
Toossi, P.; Farshchian, M.; Malekzad, F.; Mohtasham, N.; Kimyai-Asadi, A.
Journal of Drugs in Dermatology Jdd 7(12): 1149-1152
2008
ISSN/ISBN: 1545-9616 PMID: 19137768 Document Number: 15055
Acne is a common inflammatory skin disorder. Oral antibiotics play a significant clinical role in treating acne. The purpose of this study was to compare the efficacy of doxycycline at antimicrobial and subantimicrobial doses for the treatment of acne. A prospective, randomized, double-blind, controlled trial was performed. One hundred patients with moderate facial acne were randomized into 2 treatment groups, one receiving a tablet containing 20 mg of doxycycline to be taken twice daily and the other receiving a tablet containing 100 mg of doxycycline and a matching placebo tablet to be taken twice daily. Subantimicrobial-dose doxycycline administered twice daily for 3 months in patients with moderate inflammatory acne results in significant reduction in the number of total inflammatory lesions. There was an 84% reduction in number of papules and a 90% reduction in number of pustules with treatment. Subantimicrobial-dose doxycycline is an effective treatment for patients with moderate acne vulgaris.
Document emailed within 1 workday
